Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
2.020
+0.060 (3.06%)
Feb 18, 2026, 12:20 PM EST - Market open
Traws Pharma Market Cap
Traws Pharma has a market cap or net worth of $16.14 million as of February 18, 2026. Its market cap has decreased by -39.27% in one year.
Market Cap
16.14M
Enterprise Value
9.24M
1-Year Change
-39.27%
Ranking
Category
Stock Price
$2.02
Market Cap Chart
Since July 25, 2013, Traws Pharma's market cap has decreased from $409.28M to $16.14M, a decrease of -96.06%. That is a compound annual growth rate of -22.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 15.66M | 73.45% |
| Dec 31, 2025 | 9.03M | -72.02% |
| Dec 31, 2024 | 32.27M | 106.05% |
| Dec 29, 2023 | 15.66M | 15.90% |
| Dec 30, 2022 | 13.51M | -74.64% |
| Dec 31, 2021 | 53.27M | -38.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Citius Pharmaceuticals | 17.12M |
| FibroBiologics | 16.70M |
| Pasithea Therapeutics | 16.40M |
| Klotho Neurosciences | 16.24M |
| Intensity Therapeutics | 15.85M |
| Hoth Therapeutics | 15.82M |
| Curis | 15.75M |
| Lexaria Bioscience | 15.49M |